(Reuters) -Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in ... late-stage ...

Analysts cited data from a phase one study showing the highest dose of Amgen’s MariTide was linked to roughly 4% loss of bone ...

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.

Novo Nordisk is working on a new obesity drug that could help patients shed more than any other weight-loss drug on the ...

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here’s how Americans ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

The death of a nurse from North Lanarkshire has been linked to the use of a weight-loss drug recently approved for use on the ...

Published Just now A new weight loss drug target may help reduce appetite and burn calories without causing sickness, ...